Ad hoc:Carl Zeiss Meditec AG:Ad hoc: Carl Zeiss Meditec AG proposes increased dividend for financial

Ad hoc:Carl Zeiss Meditec AG:Ad hoc: Carl Zeiss Meditec AG proposes increased dividend for financial year 2009/2010

ID: 49577

(Thomson Reuters ONE) -
Carl Zeiss Meditec AG /
/
Ad hoc: Carl Zeiss Meditec AG proposes increased dividend for financial year
2009/2010
Processed and transmitted by Thomson Reuters.
The issuer is solely responsible for the content of this announcement.

(Jena, 9 December 2010) Carl Zeiss Meditec AG (ISIN: DE0005313704) plans to
distribute an increased dividend for financial year 2009/2010. At today's
Supervisory Board meeting to adopt the financial statements for financial year
2009/2010 the Company's Supervisory Board approved the Management Board's
proposal for the utilisation of profits. This decision was made around 4.30 p.m.
The proposal stipulates the payment of a regular dividend of ? 0.22 (previous
year: ? 0.18) per no-par value share. In addition to this, a one-off special
dividend of ? 0.33 per no-par value share is planned to be paid. Therefore, the
proposed dividend totals at ? 0.55 per no-par value share. This shall to be
proposed to the Annual General Meeting for financial year 2009/2010 on 12 April
2011.



--- End of Message ---

Carl Zeiss Meditec AG
Goeschwitzer Strasse 51-52 Jena Germany

WKN: 531370;ISIN: DE0005313704;Index:Prime All Share,TECH All Share,TecDAX;
Listed: Freiverkehr in Börse Stuttgart,
Freiverkehr in Hanseatische Wertpapierbörse zu Hamburg,
Freiverkehr in Börse Berlin,
Freiverkehr in Börse Düsseldorf,
Freiverkehr in Bayerische Börse München,
Freiverkehr in Niedersächsische Börse zu Hannover,
Prime Standard in Frankfurter Wertpapierbörse,
Regulierter Markt in Frankfurter Wertpapierbörse;





This announcement is distributed by Thomson Reuters on behalf of
Thomson Reuters clients. The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and
other applicable laws; and




(ii) they are solely responsible for the content, accuracy and
originality of the information contained therein.

Source: Carl Zeiss Meditec AG via Thomson Reuters ONE

[HUG#1471057]


Weitere Infos zu dieser Pressemeldung:
Unternehmensinformation / Kurzprofil:
drucken  als PDF  an Freund senden  Study shows Novartis drug Afinitor® plus hormonal therapy delays disease progression in advanced metastatic breast cancer patients Neuer Managementvertrag; Kreditfazilität
Bereitgestellt von Benutzer: hugin
Datum: 09.12.2010 - 17:25 Uhr
Sprache: Deutsch
News-ID 49577
Anzahl Zeichen: 2292

contact information:
Town:

Jena



Kategorie:

Business News



Diese Pressemitteilung wurde bisher 364 mal aufgerufen.


Die Pressemitteilung mit dem Titel:
"Ad hoc:Carl Zeiss Meditec AG:Ad hoc: Carl Zeiss Meditec AG proposes increased dividend for financial year 2009/2010"
steht unter der journalistisch-redaktionellen Verantwortung von

Carl Zeiss Meditec AG (Nachricht senden)

Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).

ZEISS removes barriers for Minimally Invasive Spine Surgery ...

At this year?s NASS Annual Meeting in Los Angeles, USA, the ZEISS Medical Technology business segment introduces an innovative visualization system ? TIVATO? 700 from ZEISS ? to the spine community. ?When developing the ZEISS TIVATO 700 we involved e ...

Alle Meldungen von Carl Zeiss Meditec AG



 

Werbung



Sponsoren

foodir.org The food directory für Deutschland
News zu Snacks finden Sie auf Snackeo.
Informationen für Feinsnacker finden Sie hier.

Firmenverzeichniss

Firmen die firmenpresse für ihre Pressearbeit erfolgreich nutzen
1 2 3 4 5 6 7 8 9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z